Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 March 2005

Volume 191, Number 6
The Journal of Infectious Diseases 2005;191:1005–1009
0022-1899/2005/19106-0025$15.00
DOI: 10.1086/427781
MAJOR ARTICLE

Clinical and Parasitological Characteristics of Puerperal Malaria

Michael Ramharter,1,2,3

Martin P. Grobusch,1,2

Georg Kießling,1,2

Ayola A. Adegnika,1,2

Ulrike Möller,1,2

Selidji T. M. Agnandji,1

Martin Kramer,1,2

Norbert Schwarz,1,2

Jürgen F. J. Kun,2

Sunny Oyakhirome,1

Saadou Issifou,1,2

Steffen Borrmann,1,2

Bertrand Lell,1,2

Benjamin Mordmüller,1,2 and

Peter G. Kremsner1,2

1Medical Research Unit, Albert Schweitzer Hospital, Lambaréné, Gabon; 2Institute for Tropical Medicine, Department of Parasitology, University of Tübingen, Tübingen, Germany; 3Department of Internal Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria

Background.Women with semi‐immunity to malaria who live in regions where the disease is endemic are at increased risk for more frequent and severe episodes of malaria during pregnancy. Recent findings indicate that this increased risk might persist beyond delivery, but the underlying mechanisms for this change in risk are poorly understood.

Methods.One hundred fifty women were included in a cohort study in Lambaréné, Gabon, and were actively followed up weekly for 10 weeks after delivery, as were nonpregnant control women who had been matched to them by location and age. Parasites in samples of placenta and blood were genotyped by use of polymerase chain reaction amplification of the merozoite surface antigen 2 gene and the subtelomeric variable open reading frame gene of Plasmodium falciparum.

Results.Eleven puerperal women had cases of clinical malaria, compared with 1 control woman (rate ratio, 9.8; ). Eighteen puerperal women had P. falciparum parasitemia, compared with 6 control women (rate ratio, 2.7; ). Five of 16 puerperal women (31%) with parasitemia on follow‐up had identical parasites in their placentas and blood, and 11 of these cases (69%) were the result of reinfection. Puerperal women remained at equal risk for the development of parasitemia throughout the first 10 weeks after delivery. Use of bed nets, use of chloroquine prophylaxis during pregnancy, presence of malaria episodes during pregnancy, gravidity, and age were not associated with the acquisition of parasitemia during follow‐up.

Conclusions.Compared with nonpregnant women, puerperal women have a considerably increased risk for the development of malaria and/or parasitemia. This increased risk is caused both by the recurrence of P. falciparum parasitemia and by the increased susceptibility to new infections, although the latter plays a more significant role.

Received 29 July 2004; accepted 17 September 2004; electronically published 4 February 2005.

Reprints or correspondence: Dr. Michael Ramharter, Medical Research Unit, Albert Schweitzer Hospital, B.P. 118, Lambaréné, Gabon; or Dept. of Internal Medicine I, Div. of Infectious Diseases, Medical University of Vienna, Währinger Gürtel 18‐20, 1090 Vienna, Austria ().

Cited by

Andrew Vallely, James McCarthy, John Changalucha, Lisa Vallely, Daniel Chandramohan. (2008) Treating malaria in pregnancy in developing countries: priorities in clinical research and drug development. Expert Review of Clinical Pharmacology 1:1, 61-72
Online publication date: 1-Feb-2008.
CrossRef
Meral Esen, Benjamin Mordmüller. (2008) Parasites and pregnancy. Wiener klinische Wochenschrift 119:23-24, 681-684
Online publication date: 1-Jan-2008.
CrossRef
Michael Ramharter, Ayola A. Adegnika, Selidji T. Agnandji, Pierre Blaise Matsiegui, Martin P. Grobusch, Stefan Winkler, Wolfgang Graninger, Sanjeev Krishna, Maria Yazdanbakhsh, Benjamin Mordmüller, Bertrand Lell, Michel A. Missinou, Elie Mavoungou, Saadou Issifou, Peter G. Kremsner. (2007) History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wiener klinische Wochenschrift 119:S3, 8-12
Online publication date: 1-Dec-2007.
CrossRef
Stephen J Rogerson, Clara Menendez. (2006) Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Review of Anti-infective Therapy 4:4, 687-702
Online publication date: 1-Sep-2006.
CrossRef
Close Popup